v3.25.3
Consolidated statements of income - EUR (€)
€ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenue:        
Healthcare services € 3,219,669 € 3,292,628 € 9,721,334 € 9,986,979
Healthcare products 1,097,603 1,037,588 3,277,466 3,058,146
Insurance contracts 567,578 429,946 1,559,217 1,205,997
Revenue 4,884,850 4,760,162 14,558,017 14,251,122
Costs of revenue:        
Healthcare services 2,478,060 2,584,886 7,642,514 7,869,631
Healthcare products 601,258 598,337 1,758,380 1,730,099
Insurance contracts 563,314 430,855 1,516,566 1,165,168
Costs of revenue 3,642,632 3,614,078 10,917,460 10,764,898
Operating (income) expenses:        
Selling, general and administrative 705,440 756,146 2,248,105 2,303,256
Research and development 37,748 40,047 119,346 133,433
Income from equity method investees (46,672) (41,248) (139,680) (102,730)
Other operating income (56,077) (191,066) (397,236) (532,494)
Other operating expense 125,274 119,509 576,844 551,261
Operating income 476,505 462,696 1,233,178 1,133,498
Other (income) expense:        
Interest income (19,159) (16,934) (55,989) (50,342)
Interest expense 93,096 99,104 285,392 306,030
Income before income taxes 402,568 380,526 1,003,775 877,810
Income tax expense 75,225 116,534 214,528 255,058
Net income 327,343 263,992 789,247 622,752
Net income attributable to noncontrolling interests 52,546 50,965 137,958 151,738
Net income attributable to shareholders of FME AG € 274,797 € 213,027 € 651,289 € 471,014
Basic earnings per share € 0.94 € 0.73 € 2.22 € 1.61
Diluted earnings per share € 0.94 € 0.73 € 2.22 € 1.61